Latest filing published 20 Apr 2026 for Cognition Therapeutics INC, €9,590.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
John Brendan Doyle discloses dealings in Cognition Therapeutics Inc to SEC (Form 4). In total, 14 filings cover trades dated from 1 May 2023 to 16 April 2026.
Purchases make up the whole of the open-market record (1 purchase, €9,590). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 13 share grants. Since January 2026: 1 purchase and no sales on the market.
The newest entry dates from 20 April 2026: an open-market purchase of €9,590, in Cognition Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations